June 2023 Br J Cardiol 2023;30:70–3 doi:10.5837/bjc.2023.017
Gustavo A Giunta, Pablo D Cutine, María F Aguiló Iztueta, Daniel Pirola, Nahuel Messina, Lorena Helman, María I Rodríguez Acuña, Ariel Kraselnik, Laura Brandani, Juan J Badimon
Introduction Overweight and obesity are a global pandemic.1 These evermore frequent conditions are associated with serious chronic diseases (e.g. diabetes mellitus, hyperlipidaemia, cancer), and incremented risk for cardiovascular events.2,3 Metabolic syndrome (MS), a constellation of anthropometric and metabolic anomalies, is frequently associated with an increased body mass index (BMI) and related to an adverse cardiovascular prognosis.4 Despite the well-established association between BMI and cardiovascular prognosis, the concept of healthy obesity has emerged in more recent years, resembling a phenotype of obesity without metabolic distur
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits